Table 2.
The mean doses for the heart, lungs, and contralateral breast for the indicated groups and techniques. The p-values presented refer to the comparison of 3DCRT and the given technique.
| Group | 3DCRT | 3DCRT-IMRT |
3DCRT-VMAT |
VMAT |
||||
|---|---|---|---|---|---|---|---|---|
| Mdn (IQR) | Mdn (IQR) | p-val. | Mdn (IQR) | p-val. | Mdn (IQR) | p-val. | ||
| Heart, Gy | 1 | 1.0 (0.9–1.3) | 1.0 (0.9–1.2) | 0.01 | 1.3 (1.1–1.5) | <0.01 | 1.4 (1.3–2.3) | <0.01 |
| 2 | 2.5 (1.6–2.6) | 2.2 (1.5–2.4) | <0.01 | 2.6 (2.0–2.8) | <0.01 | 2.6 (2.3–3.0) | 0.09 | |
| 3 | 2.5 (1.6–2.8) | 2.4 (1.7–2.5) | <0.01 | 2.8 (2.2–2.9) | <0.01 | 2.9 (2.7–3.1) | 0.01 | |
| 4 | 0.3 (0.2–0.3) | 0.3 (0.2–0.3) | <0.01 | 0.6 (0.5–0.8) | <0.01 | 0.8 (0.7–0.9) | <0.01 | |
| Lungs, Gy | 1 | 2.3 (2.1–2.4) | 2.0 (1.7–2.2) | <0.01 | 2.6 (2.3–2.8) | <0.01 | 3.0 (2.7–3.5) | <0.01 |
| 2 | 2.4 (2.0–2.7) | 2.2 (1.8–2.5) | <0.01 | 2.6 (2.2–2.9) | 0.03 | 2.7 (2.2–3.3) | 0.03 | |
| 3 | 2.4 (1.9–2.7) | 2.3 (1.8–2.4) | <0.01 | 2.5 (2.1–2.9) | <0.01 | 2.8 (2.2–3.1) | <0.01 | |
| 4 | 3.1 (2.5–3.3) | 2.6 (2.3–2.9) | <0.01 | 3.5 (3.4–3.6) | <0.01 | 3.8 (3.3–4.0) | <0.01 | |
| CB, Gy | 1 | 0.1 (0.0–0.2) | 0.1 (0.0–0.1) | 0.01 | 0.5 (0.4–0.6) | <0.01 | 0.7 (0.6–1.2) | <0.01 |
| 2 | 0.1 (0.0–0.1) | 0.1 (0.0–0.1) | <0.01 | 0.6 (0.3–0.6) | <0.01 | 1.3 (0.9–1.5) | <0.01 | |
| 3 | 0.1 (0.0–0.2) | 0.1 (0.0–0.1) | <0.01 | 0.7 (0.3–0.8) | <0.01 | 1.7 (1.0–1.9) | <0.01 | |
| 4 | 0.1 (0.0–0.2) | 0.1 (0.0–0.1) | 0.02 | 0.5 (0.3–0.7) | <0.01 | 0.9 (0.6–1.0) | <0.01 | |
Abbreviations: Mdn = median. IQR = interquartile range. CB = contralateral breast.